Personal tools

Coexpression cluster:C254: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|gostat_on_coexpression_clusters=GO:0043012!regulation of fusion of sperm to egg plasma membrane!0.0376730967742162!79400$GO:0010155!regulation of proton transport!0.0376730967742162!79400$GO:0015252!hydrogen ion channel activity!0.0376730967742162!79400$GO:0016175!superoxide-generating NADPH oxidase activity!0.0376730967742162!79400
|gostat_on_coexpression_clusters=GO:0043012!regulation of fusion of sperm to egg plasma membrane!0.0376730967742162!79400$GO:0010155!regulation of proton transport!0.0376730967742162!79400$GO:0015252!hydrogen ion channel activity!0.0376730967742162!79400$GO:0016175!superoxide-generating NADPH oxidase activity!0.0376730967742162!79400
|id=C254
|id=C254
|ontology_enrichment_celltype=CL:0000055!1.31e-20!180;CL:0000222!2.12e-18!119;CL:0000220!1.46e-15!246;CL:0002321!9.42e-15!248;CL:0000183!1.06e-12!59;CL:0000680!8.58e-12!57;CL:0000056!8.58e-12!57;CL:0000355!8.58e-12!57;CL:0000548!1.17e-11!679;CL:0000004!1.17e-11!679;CL:0000255!1.17e-11!679;CL:0000012!4.55e-11!682;CL:0000187!5.83e-11!54;CL:0002371!1.21e-10!591;CL:0000144!4.78e-10!625;CL:0000057!1.48e-09!75;CL:0000192!8.68e-09!42;CL:0000514!8.68e-09!42;CL:0000393!1.20e-08!60;CL:0000211!1.20e-08!60;CL:0000003!5.58e-08!722;CL:0000359!1.86e-07!32;CL:0000213!2.82e-07!57;CL:0000215!2.82e-07!57;CL:0002139!5.34e-07!24
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002049!5.94e-16!79;UBERON:0007798!5.94e-16!79;UBERON:0004535!2.45e-12!110;UBERON:0000055!3.30e-12!69;UBERON:0005256!3.40e-12!143;UBERON:0000914!4.86e-12!83;UBERON:0002329!4.86e-12!83;UBERON:0003077!4.86e-12!83;UBERON:0003059!4.86e-12!83;UBERON:0007282!4.86e-12!83;UBERON:0009618!4.86e-12!83;UBERON:0007285!4.86e-12!83;UBERON:0002100!6.16e-12!216;UBERON:0000490!7.40e-12!138;UBERON:0000486!9.31e-12!82;UBERON:0001009!1.92e-11!113;UBERON:0004290!1.14e-10!70;UBERON:0001981!1.89e-10!60;UBERON:0007500!1.89e-10!60;UBERON:0004537!1.89e-10!60;UBERON:0006965!1.89e-10!60;UBERON:0001637!6.23e-10!42;UBERON:0003509!6.23e-10!42;UBERON:0004572!6.23e-10!42;UBERON:0003914!1.95e-09!118;UBERON:0003104!2.05e-09!238;UBERON:0009142!2.05e-09!238;UBERON:0001134!3.95e-09!61;UBERON:0002036!3.95e-09!61;UBERON:0003082!3.95e-09!61;UBERON:0004573!4.56e-09!33;UBERON:0004571!4.56e-09!33;UBERON:0004872!8.59e-09!84;UBERON:0002385!2.37e-08!63;UBERON:0001015!2.37e-08!63;UBERON:0000383!2.37e-08!63;UBERON:0000475!4.45e-07!365;UBERON:0000119!6.19e-07!312
}}
}}

Revision as of 14:25, 21 May 2012


Full id: C254_prostate_rhabdomyosarcoma_seminal_Fibroblast_transitionalcell_Smooth_Iris



Phase1 CAGE Peaks

Hg19::chr10:33624520..33624578,-p@chr10:33624520..33624578
-
Hg19::chr10:38146468..38146475,-p12@ZNF248
Hg19::chr10:38146482..38146507,-p4@ZNF248
Hg19::chr10:4808729..4808734,-p@chr10:4808729..4808734
-
Hg19::chr11:1221057..1221104,+p1@uc009ycs.1
Hg19::chr11:66583418..66583427,+p6@C11orf80
Hg19::chr12:52679734..52679755,-p@chr12:52679734..52679755
-
Hg19::chr13:66882589..66882629,+p@chr13:66882589..66882629
+
Hg19::chr14:62393999..62394005,+p@chr14:62393999..62394005
+
Hg19::chr14:62583348..62583354,+p3@FLJ43390
Hg19::chr15:69339407..69339410,+p3@NOX5
Hg19::chr15:74220458..74220472,-p11@LOC100287616
Hg19::chr15:74220487..74220499,-p9@LOC100287616
Hg19::chr15:74220519..74220531,-p8@LOC100287616
Hg19::chr15:74220536..74220564,-p3@LOC100287616
Hg19::chr15:74220590..74220602,-p15@LOC100287616
Hg19::chr15:74220651..74220670,-p5@LOC100287616
Hg19::chr17:46806016..46806029,-p5@HOXB13
Hg19::chr17:46806373..46806386,-p6@HOXB13
Hg19::chr17:46806404..46806415,-p7@HOXB13
Hg19::chr17:46806554..46806558,-p9@HOXB13
Hg19::chr17:49141793..49141801,-p@chr17:49141793..49141801
-
Hg19::chr1:85395365..85395368,-p6@MCOLN2
Hg19::chr20:24115408..24115418,+p@chr20:24115408..24115418
+
Hg19::chr20:58410917..58410928,+p12@PHACTR3
Hg19::chr20:58411263..58411271,+p34@PHACTR3
Hg19::chr21:46331846..46331872,-p29@ITGB2
Hg19::chr22:39410287..39410302,+p2@APOBEC3C
Hg19::chr2:189992577..189992580,-p@chr2:189992577..189992580
-
Hg19::chr2:36806022..36806034,-p20@FEZ2
Hg19::chr3:108160535..108160548,-p@chr3:108160535..108160548
-
Hg19::chr3:146464294..146464304,+p@chr3:146464294..146464304
+
Hg19::chr4:69614262..69614265,-p@chr4:69614262..69614265
-
Hg19::chr5:147297683..147297729,-p@chr5:147297683..147297729
-
Hg19::chr5:151055872..151055921,-p14@SPARC
Hg19::chr6:47010258..47010273,-p5@GPR110
Hg19::chr6:47010286..47010292,-p11@GPR110
Hg19::chr6:47010305..47010311,-p8@GPR110
Hg19::chr7:103086717..103086724,+p@chr7:103086717..103086724
+
Hg19::chr7:103086740..103086747,+p@chr7:103086740..103086747
+
Hg19::chr7:103310094..103310097,+p@chr7:103310094..103310097
+
Hg19::chr7:31855776..31855807,-p@chr7:31855776..31855807
-
Hg19::chr7:48251843..48251884,+p@chr7:48251843..48251884
+
Hg19::chr8:38687332..38687338,+p@chr8:38687332..38687338
+
Hg19::chr9:123788118..123788127,-p@chr9:123788118..123788127
-
Hg19::chr9:35753022..35753030,-p4@CU674847
Hg19::chr9:35753038..35753047,-p2@CU674847
Hg19::chr9:35753063..35753064,-p5@CU674847
Hg19::chr9:35754222..35754237,-p3@MSMP
Hg19::chr9:35754253..35754279,-p1@MSMP
Hg19::chr9:35754350..35754382,-p4@MSMP


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0043012regulation of fusion of sperm to egg plasma membrane0.0376730967742162
GO:0010155regulation of proton transport0.0376730967742162
GO:0015252hydrogen ion channel activity0.0376730967742162
GO:0016175superoxide-generating NADPH oxidase activity0.0376730967742162



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
vasculature5.94e-1679
vascular system5.94e-1679
cardiovascular system2.45e-12110
vessel3.30e-1269
trunk mesenchyme3.40e-12143
somite4.86e-1283
paraxial mesoderm4.86e-1283
presomitic mesoderm4.86e-1283
presumptive segmental plate4.86e-1283
trunk paraxial mesoderm4.86e-1283
presumptive paraxial mesoderm4.86e-1283
trunk6.16e-12216
unilaminar epithelium7.40e-12138
multilaminar epithelium9.31e-1282
circulatory system1.92e-11113
dermomyotome1.14e-1070
blood vessel1.89e-1060
epithelial tube open at both ends1.89e-1060
blood vasculature1.89e-1060
vascular cord1.89e-1060
artery6.23e-1042
arterial blood vessel6.23e-1042
arterial system6.23e-1042
epithelial tube1.95e-09118
mesenchyme2.05e-09238
entire embryonic mesenchyme2.05e-09238
skeletal muscle tissue3.95e-0961
striated muscle tissue3.95e-0961
myotome3.95e-0961
systemic artery4.56e-0933
systemic arterial system4.56e-0933
splanchnic layer of lateral plate mesoderm8.59e-0984
muscle tissue2.37e-0863
musculature2.37e-0863
musculature of body2.37e-0863
organism subdivision4.45e-07365
cell layer6.19e-07312


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.